Gene therapy for hemophilia remains a very active area of research, although it may take longer than expected. Moderated by NHF President and CEO Leonard A. Valentino, MD, this webinar will feature Glenn Pierce, MD, PhD; Steve Pipe, MD; and Margaret Ragni, MD. They will discuss the current status of gene therapies in the pipeline and other novel therapies.
